Home > SWOT Analysis > Repligen Corp (RGEN) SWOT Analysis





Repligen Corp (RGEN) SWOT Analysis Profile

Repligen Corporation, founded in 1981, develops products for the treatment of central nervous system diseases. Its Protein A products are used to produce and purify therapeutic monoclonal antibodies. It has a number of products under development to address bipolar depression and the synthesis of DNA and RNA. Headquartered in Waltham, Massachusetts, its products are distributed internationally through value-added resellers. (read full profile)

Additional Information

What is a SWOT Analysis? It is a way of evaluating the strengths, weaknesses, opportunities, and threats that affect something. See WikiWealth's SWOT tutorial for help. Remember, vote up the most important comments. Check out WikiWealth's entire database of free SWOT reports or use our SWOT analysis generator to create your own SWOT template.

Receive News & Ratings Via Email